Morpholino

MO2-fhl1b

ID
ZDB-MRPHLNO-160413-8
Name
MO2-fhl1b
Previous Names
None
Target
Sequence
5' - CCCGCGAAAAGCTGTGAGAAATAAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-fhl1b
No data available
Phenotype
Phenotype resulting from MO2-fhl1b
No data available
Phenotype of all Fish created by or utilizing MO2-fhl1b
Phenotype Fish Conditions Figures
pancreas primordium pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 5 with image from Xu et al., 2016
endoderm pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 5 with image from Xu et al., 2016
primary islet neurod1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 6 with image from Xu et al., 2016
digestive system duct pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 6 with image from Xu et al., 2016
insulin secreting cell ab2-isl labeling increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with imageFig. S13 with image from Xu et al., 2016
posterior pancreatic bud hhex expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with imageFig. S13 with image from Xu et al., 2016
somatostatin secreting cell increased amount, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
primary islet pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 6 with image from Xu et al., 2016
posterior pancreatic bud pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with imageFig. S13 with image from Xu et al., 2016
liver development decreased occurrence, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
intestine pdx1 expression decreased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with imageFig. S13 with image from Xu et al., 2016
pancreas induction increased occurrence, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
liver hhex expression decreased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with imageFig. S13 with image from Xu et al., 2016
digestive system duct neurod1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 6 with image from Xu et al., 2016
endocrine pancreas pancreas induction increased occurrence, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
pancreas primordium neurod1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 5 with image from Xu et al., 2016
insulin secreting cell increased amount, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
endoderm neurod1 expression increased distribution, abnormal WT + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 5 with image from Xu et al., 2016
endoderm lateral region EGFP expression mislocalised, abnormal nl1Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 5 with image from Xu et al., 2016
insulin secreting cell ab2-isl labeling increased distribution, abnormal s870Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
liver development decreased occurrence, abnormal s870Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
pancreas induction increased occurrence, abnormal s870Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
insulin secreting cell increased amount, abnormal s870Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
pancreatic bud endocrine cell GFP expression increased distribution, abnormal ulg515Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
endocrine pancreas pancreas induction increased occurrence, abnormal ulg515Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
pancreas endocrine cell increased amount, abnormal ulg515Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
posterior pancreatic bud ab2-isl labeling increased distribution, abnormal zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
liver development decreased occurrence, abnormal zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
insulin secreting cell GFP expression increased distribution, abnormal zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
pancreas induction increased occurrence, abnormal zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
primary islet ab2-isl labeling increased distribution, abnormal zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
insulin secreting cell increased amount, abnormal zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 2 with image from Xu et al., 2016
insulin secreting cell DsRed expression increased distribution, abnormal m1018Tg; zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
insulin secreting cell GFP expression increased distribution, abnormal m1018Tg; zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
insulin secreting cell increased amount, abnormal m1018Tg; zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
endocrine pancreas pancreas induction increased occurrence, abnormal m1018Tg; zf5Tg + MO1-fhl1b + MO2-fhl1b standard conditions Fig. 3 with image from Xu et al., 2016
posterior pancreatic bud hhex expression increased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
posterior pancreatic bud pdx1 expression increased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
intestine pdx1 expression decreased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
intestine hhex expression decreased distribution, abnormal WT + MO1-fhl1b + MO1-id2a + MO2-fhl1b standard conditions Fig. S13 with image from Xu et al., 2016
insulin secreting cell ab2-isl labeling spatial pattern, ameliorated fr13Tg + MO1-fhl1b + MO2-fhl1b heat shock Fig. S13 with image from Xu et al., 2016
insulin secreting cell ab2-isl labeling increased distribution, abnormal fr13Tg + MO1-fhl1b + MO2-fhl1b heat shock Fig. S13 with image from Xu et al., 2016
insulating cell pancreas regeneration increased rate, abnormal jh6Tg; s892Tg + MO1-fhl1b + MO2-fhl1b chemical ablation: insulin secreting cell, chemical treatment: metronidazole Fig. 6 with image from Xu et al., 2016
Citations